Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
15 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Volibris“
Suchtreffer
Begriffe & Kennungen
Volibris · 4.8 · 9 Gastrointestinal disorders Very common Nausea, diarrhoea, vomiting5 Common Abdominal pain, constipation Hepa
Eintrag öffnenVolibris · 4.8 · Decreased haemoglobin In the post-marketing period, cases of anaemia requiring blood cell transfusion have bee
Eintrag öffnenVolibris · 4.8 · Description of selected adverse reactions
Eintrag öffnenVolibris · 4.8 · Frequencies are defined as: very common (≥ 1/10); common (≥ 1/100 to <1/10); uncommon (≥1/1 000 to <1/100); ra
Eintrag öffnenVolibris · 4.8 · Hepatic enzyme elevations (2%), hepatic injury and autoimmune hepatitis (including exacerbation of underlying
Eintrag öffnenVolibris · 4.8 · Paediatric population
Eintrag öffnenVolibris · 4.8 · Peripheral oedema (37%) and headache (28%) were the most common adverse reactions observed with ambrisentan. T
Eintrag öffnenVolibris · 4.8 · Reductions in haemoglobin concentrations and haematocrit (10%) have been associated with ERAs including ambris
Eintrag öffnenVolibris · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenVolibris · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenVolibris · 4.8 · Serious adverse reactions associated with ambrisentan use include anaemia (decreased haemoglobin, decreased ha
Eintrag öffnenVolibris · 4.8 · Summary of the safety profile
Eintrag öffnenVolibris · 4.8 · System organ class Frequency Adverse reaction(s) Blood and lymphatic system Very common Anaemia (decreased hae
Eintrag öffnenVolibris · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenVolibris · 4.8 · The safety of ambrisentan in paediatric patients with PAH aged 8 to less than 18 years was evaluated in 41 pat
Eintrag öffnen